Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald G Stein

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Head Trauma Rehabilitation|April 30, 2019
How Much Can We Ask of Molecular Biomarkers? An Opinion on Pattinson et al, "Elevated Tau in Military Personnel Relates to Chronic Symptoms Following Traumatic Brain Injury"Donald G Stein
Progress in Brain Research|July 10, 2007
Sex differences in brain damage and recovery of function: experimental and clinical findingsDonald G Stein
Hormones and Behavior|May 26, 2012
A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury?Donald G Stein
Dialogues in Clinical Neuroscience|October 29, 2011
Is progesterone a worthy candidate as a novel therapy for traumatic brain injury?Donald G Stein
Metabolic Brain Disease|August 30, 2014
On improving human clinical trials to the level of animal ischemic stroke studiesDonald G Stein
Brain Research Reviews|September 11, 2007
Progesterone exerts neuroprotective effects after brain injuryDonald G Stein
Science (New York, N.Y.)|September 17, 2002
Stem cells and neurological disordersDonald G Stein
Annals of the New York Academy of Sciences|July 19, 2005
The case for progesteroneDonald G Stein
Brain Injury|August 15, 2015
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trialsDonald G Stein
Restorative Neurology and Neuroscience|April 3, 2003
Differences in memory impairment and response to GM1 ganglioside treatment following electrolytic or ibotenic acid lesions of the nucleus basalis magnocellularisLaurent Lescaudron, Donald G. Stein
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Head Trauma Rehabilitation|April 30, 2019
How Much Can We Ask of Molecular Biomarkers? An Opinion on Pattinson et al, "Elevated Tau in Military Personnel Relates to Chronic Symptoms Following Traumatic Brain Injury"Donald G Stein
Progress in Brain Research|July 10, 2007
Sex differences in brain damage and recovery of function: experimental and clinical findingsDonald G Stein
Hormones and Behavior|May 26, 2012
A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury?Donald G Stein
Dialogues in Clinical Neuroscience|October 29, 2011
Is progesterone a worthy candidate as a novel therapy for traumatic brain injury?Donald G Stein
Metabolic Brain Disease|August 30, 2014
On improving human clinical trials to the level of animal ischemic stroke studiesDonald G Stein
Brain Research Reviews|September 11, 2007
Progesterone exerts neuroprotective effects after brain injuryDonald G Stein
Science (New York, N.Y.)|September 17, 2002
Stem cells and neurological disordersDonald G Stein
Annals of the New York Academy of Sciences|July 19, 2005
The case for progesteroneDonald G Stein
Brain Injury|August 15, 2015
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trialsDonald G Stein
Restorative Neurology and Neuroscience|April 3, 2003
Differences in memory impairment and response to GM1 ganglioside treatment following electrolytic or ibotenic acid lesions of the nucleus basalis magnocellularisLaurent Lescaudron, Donald G. Stein
Pageof 13